PubMed

Photodynamic therapy with verteporfin is effective, but how big is its effect? Results of a systematic review.

Meads C, Hyde C.

Br J Ophthalmol. 2004 Feb;88(2):212-7. Review.PMID: 14736777 [PubMed - indexed for MEDLINE]Related articlesFree article

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.

Azab M, Benchaboune M, Blinder KJ, Bressler NM, Bressler SB, Gragoudas ES, Fish GE, Hao Y, Haynes L, Lim JI, Menchini U, Miller JW, Mones J, Potter MJ, Reaves A, Rosenfeld PJ, Strong A, Su XY, Slakter JS, Schmidt-Erfurth U, Sorenson JA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group; Verteporfin in Photodynamic Therapy (VIP) Study Group.

Retina. 2004 Feb;24(1):1-12.PMID: 15076937 [PubMed - indexed for MEDLINE]Related articles

A preliminary benefit-risk assessment of verteporfin in age-related macular degeneration.

Wickens J, Blinder KJ.

Drug Saf. 2006;29(3):189-99. Review.PMID: 16524319 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy for neovascular age-related macular degeneration.

Wormald R, Evans J, Smeeth L, Henshaw K.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD002030. Review.PMID: 17636693 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy for neovascular age-related macular degeneration.

Wormald R, Evans J, Smeeth L, Henshaw K.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002030. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD002030. PMID: 16235294 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in Canada.

Earnshaw SR, Moride Y, Rochon S.

Clin Ther. 2007 Sep;29(9):2096-106; discussion 2094-5.PMID: 18035208 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.

Azab M, Boyer DS, Bressler NM, Bressler SB, Cihelkova I, Hao Y, Immonen I, Lim JI, Menchini U, Naor J, Potter MJ, Reaves A, Rosenfeld PJ, Slakter JS, Soucek P, Strong HA, Wenkstern A, Su XY, Yang YC; Visudyne in Minimally Classic Choroidal Neovascularization Study Group.

Arch Ophthalmol. 2005 Apr;123(4):448-57.PMID: 15824216 [PubMed - indexed for MEDLINE]Related articles

Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4.

Pieramici DJ, Bressler SB, Koester JM, Bressler NM.

Arch Ophthalmol. 2006 May;124(5):660-4.PMID: 16682587 [PubMed - indexed for MEDLINE]Related articlesFree article

Photodynamic therapy for neovascular age-related macular degeneration.

Wormald R, Evans J, Smeeth L, Henshaw K.

Cochrane Database Syst Rev. 2003;(2):CD002030. Review. Update in: Cochrane Database Syst Rev. 2005;(4):CD002030. PMID: 12804420 [PubMed - indexed for MEDLINE]Related articles

Encouraging results of photodynamic therapy with Visudyne in a clinical patient material of age-related macular degeneration.

Frennesson CI, Nilsson SE.

Acta Ophthalmol Scand. 2004 Dec;82(6):645-50.PMID: 15606458 [PubMed - indexed for MEDLINE]Related articles

Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3.

Arnold JJ, Blinder KJ, Bressler NM, Bressler SB, Burdan A, Haynes L, Lim JI, Miller JW, Potter MJ, Reaves A, Rosenfeld PJ, Sickenberg M, Slakter JS, Soubrane G, Strong HA, Stur M; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group.

Am J Ophthalmol. 2004 Apr;137(4):683-96.PMID: 15059708 [PubMed - indexed for MEDLINE]Related articles

Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.

Kourlas H, Abrams P.

Clin Ther. 2007 Sep;29(9):1850-61. Review.PMID: 18035187 [PubMed - indexed for MEDLINE]Related articles

Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.

Verteporfin Roundtable Participants.

Retina. 2005 Feb-Mar;25(2):119-34. Review.PMID: 15689800 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP report no. 8.

Kaiser PK; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

Graefes Arch Clin Exp Ophthalmol. 2006 Sep;244(9):1132-42. Epub 2006 Mar 15.PMID: 16538452 [PubMed - indexed for MEDLINE]Related articles

Impact of lesion size on photodynamic therapy with verteporfin of predominantly classic lesions in age related macular degeneration.

Arias L, Pujol O, Berniell J, Rubio M, Roca G, Castillo L, Acebes E.

Br J Ophthalmol. 2005 Mar;89(3):312-5.PMID: 15722311 [PubMed - indexed for MEDLINE]Related articlesFree article

Preserving vision with verteporfin photodynamic therapy.

Yang YC.

Hosp Med. 2004 Jan;65(1):39-43. Review.PMID: 14964795 [PubMed - indexed for MEDLINE]Related articles

Spotlight on verteporfin in subfoveal choroidal neovascularisation.

Keam SJ, Scott LJ, Curran MP.

Drugs Aging. 2004;21(3):203-9. Review.PMID: 14979737 [PubMed - indexed for MEDLINE]Related articles

Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case.

Smith DH, Fenn P, Drummond M.

Br J Ophthalmol. 2004 Sep;88(9):1107-12.PMID: 15317697 [PubMed - indexed for MEDLINE]Related articlesFree article

Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation.

Colquitt JL, Jones J, Tan SC, Takeda A, Clegg AJ, Price A.

Health Technol Assess. 2008 May;12(16):iii-iv, ix-201. Review.PMID: 18462575 [PubMed - indexed for MEDLINE]Related articlesFree article

Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.

Chaudhary V, Mao A, Hooper PL, Sheidow TG.

Ophthalmology. 2007 Dec;114(12):2183-9.PMID: 18054638 [PubMed - indexed for MEDLINE]Related articles